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Purpose: Soft tissue sarcoma of the hand is rare, and one of the most common histological diagnosis is synovial
sarcoma. We report the clinical outcomes of patients with synovial sarcoma of the hand and discuss treatment
strategies.
Methods: We reviewed five patients with synovial sarcoma of the hand treated at our institutions from 1983 to
2013. The mean patient age at the time of diagnosis was 36.6 years (range, 20–62 years). Two patients underwent
marginal excision after neoadjuvant chemotherapy, followed by radiation therapy, one underwent wide local
excision and two received chemotherapy and radiation therapy.
Results: The average duration of follow-up for all patients was 88.2 months (range, 14–218 months). Two patients
continuously remained disease free, two experienced local recurrence requiring additional surgery and then showed
no evidence of disease, and one who had distant metastasis at diagnosis died of the disease. No patients
developed lymph node metastasis. The estimated 5-year overall survival was 80%.
Conclusions: Our case series suggests that patients with localised synovial sarcoma of the hand may have
favourable outcomes. Wide excision or marginal excision, followed by radiation therapy combined with
chemotherapy, represent acceptable treatment strategies for synovial sarcoma of the hand. Regional lymph node
dissection does not seem to be essential for synovial sarcoma of the hand.
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Soft tissue sarcoma of the hand is rare, with an inci-
dence of approximately 2%–4% of limb and trunk tu-
mours (Pradhan et al. 2008; McPhee et al. 1999). The
histological types of soft tissue sarcoma in the hand are
limited (Pradhan et al. 2008). The most frequent diagno-
ses are synovial sarcoma, clear cell sarcoma and epitheli-
oid sarcoma (Pradhan et al. 2008; Brien et al. 1995;
Puhaindran et al. 2011). Most sarcomas of the hand are
currently treated with a multimodality strategy including
limb-sparing surgery (Hsu et al. 2007). For epithelioid
sarcoma, an exceptionally wide excision and regional
lymph node dissection are recommended because of
the increased risk of metastasis to the lymph nodes* Correspondence: hidetatsu77@gmail.com
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in any medium, provided the original work is p(Brien et al. 1995; Kawai et al. 2002). Pradhan et al. re-
ported that clear cell sarcoma subtype is correlated
with a poor survival rate due to the high risk of local
recurrence (Pradhan et al. 2008). As mentioned above,
the treatment strategy for soft tissue sarcoma of the
hand may differ among tumour subtypes because of
differences in local recurrence and metastatic potential.
The purpose of this study was to review the clinical out-
comes of patients with synovial sarcoma of the hand
treated at our institutions, and to discuss appropriate
treatment strategies for synovial sarcoma of the hand.Materials and methods
We performed a retrospective review of all patients with
a synovial sarcoma of the hand who were treated at our
institutions over a period of 30 years from 1983 to 2013.
Among 137 synovial sarcoma patients, five with a syn-
ovial sarcoma of the hand were identified from then Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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the patients are summarised in Table 1. All patients were
male with the mean age of 36.6 years (range, 20–62
years), and all patients had tumours that were over the
dorsum of the hand. All patients gave informed consent
for their data to be included in this study. The ethical
committee of our institute gave institutional review board
approval to this retrospective study.
All patients were staged with computed tomography
(CT) scanning of the chest and magnetic resonance im-
aging (MRI) of the hand. The American Joint Committee
on Cancer (AJCC) staging system was used to stage the
tumours (Greene et al. 2002). Three patients had AJCC
stage IIA tumours, one had a stage IIB tumour and one
had a stage IV tumour.
Two patients underwent biopsy at our institutions
(Cases 3 and 4). Of these two patients, one was treated
with marginal excision after neoadjuvant chemotherapy,
followed by radiation therapy (Figure 1), and the other
patient who had distant metastasis at diagnosis refused
surgery and received chemotherapy and radiation ther-
apy. Three patients underwent inappropriate surgical ex-
cisions without wide safety margins in another hospital
and required further treatment (Cases 1, 2 and 5). Of
these three patients, one developed multiple local recur-
rences and underwent marginal excision to avoid hand
amputation and preserve hand function after neoadjuvant
chemotherapy followed by radiation therapy, one under-
went wide excision with free tendon graft reconstruction,
and the third refused surgery and received chemotherapy
and radiation therapy. From 1983 to 1996, the chemother-
apy regimen was dacarbazine, vincristine, nimustine, and
interferon β (dacarbazine, 140 mg/m2/day over 1–5 days;
vincristine, 1.5 mg/m2 only on the first day; nimustine,
80 mg/m2 only on the first day and interferon β, 6 × 106Table 1 Patient summary
Case/sex/age Presentation Location Maximu
1/M/45 After previous surgery Dorsum
2/M/23 After previous surgery Dorsum
3/M/62 Primary Dorsum
4/M/20 Primary Dorsum
5/M/33 After previous surgery Dorsum
Case Procedure Margins
1 Marginal excision Negative
2 Wide excision with free tendon graft Negative
3 Marginal excision with IORTG Negative
4 No operation -
5 *Double ray amputation Negative
CTx, chemotherapy; RTx, radiation therapy.
NED, no evidence of disease; CDF, continuous disease free; DOD, dead of disease; IO
*operation was performed after local recurrence.U/day for 1–5 days). After 1997, the regimen was a combin-
ation of doxorubicin and ifosfamide (doxorubicin, 30 mg/
m2/day for 1–2 days and ifosfamide, 2.5 g/m2/day for 1–4
days) or high-dose ifosfamide (3 g/m2/day for 1–5 days).
Results
The average duration of follow-up for all patients was
88.2 months (range, 14–218 months). The presented symp-
toms included pain and swelling in one patient and swelling
only in four patients. The mean duration of symptoms be-
fore diagnosis was 8.2 months (range, 1-12 months).
Two patients developed local recurrence, and both were
treated with unplanned excisions at another hospital. One
(Case 1) received repeated marginal excision to avoid hand
amputation, followed by radiation therapy, and the other
(Case 5) underwent double ray amputation after local re-
currence, because the patient already had received radi-
ation therapy and could not undergo marginal excision
followed by radiation therapy (Figure 2). In addition, the
latter patient developed metastasis to the lung after initial
presentation and underwent pulmonary metastasectomy.
No patients developed lymph node metastasis.
During the previous follow-up, two patients continu-
ously remained disease free, two showed no evidence of
disease after treatment for local recurrence and one died
of distant metastases. The estimated 5-year overall sur-
vival was 80%.
Discussion
Synovial sarcoma accounts for 5%–10% of all soft tissue
sarcomas, frequently affecting adolescents and young
adults and predominantly occurs in the extremities
(Goldblum et al. 2013). Synovial sarcoma arising in the
upper extremities, which accounts for approximately 10%–
15% of all cases, are fairly evenly distributed among them dimension (cm) AJCC stage CTx RTx Follow-up (months)
4 IIA Yes Yes 63
3 IIA No No 218
8 IIB Yes Yes 43
6 IV Yes Yes 14







(Persistent disease) Yes DOD
Yes Yes NED
RTG, intraoperative extracorporeal autogenous irradiated tendon grafts;
Figure 1 Representative case: case 3. (a) A 62-year-old male patient with synovial sarcoma in the dorsoradial aspect of the hand. (b) Magnetic
resonance imaging (MRI) of the tumour showed isointensity on a T1 image, (c) inhomogeneous high on a T2 image and (d) enhancement with the use
of gadolinium. The mass spanned the first, second and third compartments of the extensor tendon sheath but with no evidence of bone involvement.
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and hand (Goldblum et al. 2013). In our study, 4% of syn-
ovial sarcomas were observed in the hand, and this inci-
dence is similar to that of all extremity-related sarcomas
(Pradhan et al. 2008; McPhee et al. 1999).Figure 2 Recurrent synovial sarcoma in the dorsum of the hand: case
(b) isointensity on a T1 image and (c) high intensity on a T2 image. The mThe typical presentation of synovial sarcoma of the hand
is a slow-growing mass. Because of the rarity of the soft tis-
sue sarcoma of the hand, 38%–95% of these tumours are
treated by unplanned excision before referral to a specialist
oncological center (Pradhan et al. 2008; Lin et al. 2002).5. (a) MRI of the tumour showed high intensity on T1 fat sat image,
ass spanned the third and fourth metacarpal bones.
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exists between previous surgical excision and the risk of
local recurrence or overall survival (Pradhan et al.
2008). However, Talbot et al. reported that an un-
planned excision represents a larger operation requiring
flap coverage in affected patients (Talbot et al. 2008). In
the present report, three of the five patients had been
treated with an unplanned excision. One of the three
patients underwent free tendon graft reconstruction,
but no patients required flap coverage. Moreover, all of
these three patients experienced a favourable outcome
after multimodal treatment. In cases of large skin de-
fects after surgical excision, skin grafting and flap
coverage are important options. The radial forearm
flap and the reversed radial forearm flap can be used to
effectively cover large soft tissue defects in the hand
(Talbot et al. 2008; Ferguson 2005). Tendons can often be
resected with the tumours and reconstructed with free
tendon grafts from the palmaris longus. However, when
multiple tendons were surrounded by the tumours, we
previously re-implanted intraoperative extracorporeal
autogenous irradiated tendon grafts to restore hand func-
tion (Araki et al. 1999).
Because of its complex anatomy and limited tissue vol-
ume, soft tissue sarcoma of the hand has a tendency to
rapidly spread between compartments which makes ex-
cision with a wide margin difficult (Pradhan et al. 2008;
Kawai et al. 2002). Unfortunately, the minimal accept-
able margin has not been established (Siegel et al. 2007).
Talbert et al. reported the lack of a survival benefit from
amputation in patients with soft tissue sarcoma of the dis-
tal extremities and recommended conservation surgery
and radiation therapy (Talbert et al. 1990). In contrast,
Brien et al. reported that adjuvant radiotherapy could not
compensate for positive surgical margins (Brien et al.
1995). Two independent investigators emphasised the im-
portance of negative surgical margins for local control and
prevention of metastatic disease (Pradhan et al. 2008;
Puhaindran et al. 2011). However, those studies in-
cluded various tumour sub-types. Few reports have fo-
cused on synovial sarcoma of the hand (Dreyfuss et al.
1986; Michal et al. 2006), and the best treatment strat-
egy for synovial sarcoma of the hand remains unknown.
Synovial sarcoma is relatively chemosensitive (Canter et al.
2008; Rosen et al. 1994). Therefore, our approach has been
to perform marginal excision, avoiding amputation of the
entire hand, followed by radiation therapy combined with
chemotherapy to preserve hand function and to reduce
the risk of local recurrence or distant failure when it is dif-
ficult to achieve wide local excision. However, we assume
that amputation is still required when an important neu-
rovascular structure cannot be preserved or when local re-
currence has occurred after postoperative radiotherapy.
Some authors have reported the importance of regionallymph node dissection for some sub-types of sarcoma of
the hand (Brien et al. 1995; Kawai et al. 2002). Although
the small number of patients is a limitation of the present
study, no patients developed lymph node metastasis in
this study. In a previous case series, Brien et al. de-
scribed the clinical features of soft tissue sarcoma of the
hand (Brien et al. 1995), and of the 23 patients in that
series, 8 had synovial sarcomas and none of them devel-
oped lymph node metastasis. Therefore, we believe that
regional lymph node dissection is not essential for pa-
tients with synovial sarcoma of the hand.
The favourability of prognosis in patients with synovial
sarcoma of the hand is controversial. Canter et al.
reviewed 255 patients with localised synovial sarcoma of
all anatomic sites and reported a 5-year disease-specific
survival of 72%; an upper extremity location was associ-
ated with favourable prognosis (Canter et al. 2008).
Dreyfuss et al. reviewed 44 cases of synovial sarcoma of
the hand that were treated over the period from 1934 to
1984 and reported a 5-year overall survival of only 18%
(Dreyfuss et al. 1986). However, of those 44 cases, 13 pa-
tients (30%) were treated with radiation therapy and only
two patients (5%) were treated with chemotherapy. In
our previous 30-year series, the estimated 5-year overall
survival was 80%. Improvements in pre-operative im-
aging and adjuvant therapies may have contributed to
patient survival in our current series.
In conclusion, we report five cases of synovial sarcoma
of the hand. The clinical outcomes of synovial sarcoma of
the hand were favourable when distant metastasis was not
present at diagnosis. Patient survival was similar to that
for synovial sarcoma in all locations. Wide excision or
marginal excision, followed by radiation therapy combined
with chemotherapy, are acceptable treatment strategies for
synovial sarcoma of the hand. Regional lymph node dis-
section does not seem to be essential for synovial sarcoma
of the hand.
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